Westmore · UDRP decision
WIPO · Case No. D2005-0518

Buyallegra-d.com + 5 more domains

TransferWIPO-indexed · informational, not legal advice

The supplied WIPO case metadata records a transfer decision concerning six domain names. Because no decision text or decision pages were supplied and the decision is marked as not published, the panel's analysis of the three UDRP elements is unavailable.

Outcome
Transfer
At a glance
Provider
WIPO
Outcome
Transfer
Decision date
2005-07-13
Panelist(s)
Meijboom, Alfred
Complainant
Aventis Pharma Deutschland GMBH Aventis Pharma SA Aventis Pharmaceuticals Inc Merrell Pharmaceuticals Inc.
Respondent
Jonathan Valicenti
Disputed domain(s)
buyallegra-d.com, buyallegrad.com, buyamaryl.com, buyarava.com + 2 more
Domain history UDRP Intelligence

The timeline behind buyallegra-d.com

Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.

Westmore reconstructs the full history behind buyallegra-d.com — from public RDAP and the Internet Archive — as part of UDRP Intelligence:

Registration → decision → today timeline
Archived Wayback evidence of what the site showed
Registry bad-faith signals
The live current registrant
Available in UDRP Intelligence
Outcome by domain

How each disputed name was decided in this proceeding.

buyallegra-d.comTransferred
buyallegrad.comTransferred
buyamaryl.comTransferred
buyarava.comTransferred
buybenzaclin.comTransferred
buyddavp.comTransferred
Verified public record
Outcome & remedy
Complaint granted. Panel ordered transfer of buyallegra-d.com.
Reverse Domain Name Hijacking
No RDNH raised.
Westmore Insight

The record identifies a multi-domain transfer proceeding but offers no published reasoning. It is therefore useful for outcome and party indexing, but not for evaluating the panel's application of the UDRP elements.

The three-part test
Identical or confusingly similarunclear
Rights or legitimate interestsunclear
Registered and used in bad faithunclear

Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.

Case details
Provider
WIPO
Outcome
Transfer
Decision date
2005-07-13
Panel
Meijboom, Alfred
Full decision

Full decision text is not available in Westmore's current record. The decision below is summarized from the verified public record; you can read the complete decision at the authoritative source.

View original source at WIPO
Beyond the decision

What Westmore sees around buyallegra-d.com

The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.

Connected to Westmore UDRP Intelligence
115,979 decisions · citations · panelists · parties · domain history
Eleanor · UDRP intelligence
Ask Eleanor about this decision
Ask Eleanor about this decision

A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.

Unlocking Eleanor for this case uses 1 of your complimentary Intelligence unlocks· 3 remaining

Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.

Westmore Professional · Unlock the intelligence

The decision is only the beginning.

You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.

Citation Intelligence
How this decision is cited and treated across the corpus.
Panelist Intelligence
The panel's tendencies, outcomes and reasoning patterns.
Domain History
Ownership chronology — creation vs. respondent acquisition.
Opposing-Party Research
Complainant, counsel and portfolio context.
Independent Case Review
Eleanor challenges your filing before the other side does.
Professional Matters
Open, research and manage matters end to end.
$395/month
Unlock Westmore Professional Annual & firm seats available · cancel anytime
Take the next step
Westmore UDRP · find the right service

Westmore UDRP records draw on WIPO-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.

Essential cookies only. Nothing is sold or shared.